2445597-31-7
2445597-31-7
Chemical Structure
AB-836
- CAS No.: 2445597-31-7
- Formula:C20H15F3N4O2
- Molecular Weight:400.35
IUPAC Name: tert-butyl piperazine-1-carboxylate-3,3,5,5-d4
InChIKey: WKCMLORRPISTPL-SNVBAGLBSA-N
SMILES: FC1=C(C#N)C=C(NC(N(C)[C@H](C)C2=CNC(C3=C2C=C(F)C(F)=C3)=O)=O)C=C1
Biological Activity: AB-836 is an orally active HBV capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein. AB-836 can be used in research related to chronic hepatitis B[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AB-836 | 99.13% | AB-836 is an orally active HBV capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein. AB-836 can be used in research related to chronic hepatitis B. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Degasperi E, et al. Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. Viruses. 2022;14(11):2404. Published 2022 Oct 29. [Content Brief]
- [2]. Lam AM, et al. Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus. Antiviral Res. 2024;231:106010. [Content Brief]
Keywords
